BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1338226)

  • 1. [Lymphoproliferative syndromes associated with Epstein-Barr virus in transplantation].
    Garnier JL; Touraine JL; Berger F; Magaud JP; Lefrançois N; Pouteil-Noble C; Betuel H; Martin X; Dubernard JM; Lenoir G
    Presse Med; 1992 Dec; 21(41):1994-6. PubMed ID: 1338226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation.
    Garnier JL; Berger F; Betuel H; Vuillaume M; Chapuis-Cellier C; Blanc N; Faure JL; Dubernard JM; Lenoir G; Touraine JL
    Nephrol Dial Transplant; 1989; 4(9):818-23. PubMed ID: 2560533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease after transplantation.
    Garnier JL; Lebranchu Y; Dantal J; Bedrossian J; Cahen R; Assouline D; Jaccard A; Fetissoff F; Moreau A; Martin X; Delsol G; Berger F; Touraine JL
    Transplantation; 1996 Jan; 61(1):71-6. PubMed ID: 8560577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphoma with bladder involvement and renal transplantation].
    Chebil M; Martin X; Friaa S; Ezzeddine W; Garnier JL; Desmettre O; Maréchal JM; Gelet A; Dubernard JM
    Prog Urol; 1995 Feb; 5(1):102-5. PubMed ID: 7719353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
    Milpied N; Vasseur B; Parquet N; Garnier JL; Antoine C; Quartier P; Carret AS; Bouscary D; Faye A; Bourbigot B; Reguerre Y; Stoppa AM; Bourquard P; Hurault de Ligny B; Dubief F; Mathieu-Boue A; Leblond V
    Ann Oncol; 2000; 11 Suppl 1():113-6. PubMed ID: 10707791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency.
    Cohen JI
    Medicine (Baltimore); 1991 Mar; 70(2):137-60. PubMed ID: 1848644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z; Amlot P; Lachmanan SR; Tur-Kaspa R; Rolles K; Burroughs AK
    Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-B cell antibodies for the treatment of monoclonal Epstein-Barr virus-induced lymphoproliferative syndrome after multivisceral transplantation.
    Lazarovits AI; Tibbles LA; Grant DR; Ghent CN; Wall WJ; White MJ; Joncas JH
    Clin Invest Med; 1994 Dec; 17(6):621-5. PubMed ID: 7895425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
    Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
    Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.
    Fischer A; Blanche S; Le Bidois J; Bordigoni P; Garnier JL; Niaudet P; Morinet F; Le Deist F; Fischer AM; Griscelli C
    N Engl J Med; 1991 May; 324(21):1451-6. PubMed ID: 2023604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained remission of an extensive monoclonal, Epstein-Barr virus-associated diffuse large B cell lymphoma in a kidney-pancreas transplant recipient.
    Manz MG; Berger C; Horny HP; Beck R; Brugger W; Viebahn R; Kanz L; Knecht H
    Transplantation; 2002 Mar; 73(6):995-7. PubMed ID: 11923707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma arising from donor lymphoid cells after renal and pancreatic transplantation.
    Cibeira MT; Lopez-Guillermo A; Colomer D; Ricart MJ; Alcaraz A; Martinez A; Campo E; Montserrat E
    Ann Hematol; 2003 Feb; 82(2):131-135. PubMed ID: 12601496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
    Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
    Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM
    Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.
    Davis CL; Harrison KL; McVicar JP; Forg PJ; Bronner MP; Marsh CL
    Clin Transplant; 1995 Feb; 9(1):53-9. PubMed ID: 7742583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
    J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation.
    Gomyo H; Murayama T; Kizaki T; Mizuno I; Kitaori K; Sao H; Tobinai K; Koizumi K; Imoto S
    Bone Marrow Transplant; 2000 Sep; 26(5):577-9. PubMed ID: 11019851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoblastic lymphoma after bone marrow graft. Apropos of a case treated by OKT3 monoclonal antibodies for an acute graft versus host reaction].
    Faure P; d'Agay MF; Tricot G; Gluckman E; Brocheriou C
    Ann Pathol; 1986; 6(2):137-43. PubMed ID: 3015160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thoracic presentations of posttransplant lymphoproliferative disorders.
    Halkos ME; Miller JI; Mann KP; Miller DL; Gal AA
    Chest; 2004 Dec; 126(6):2013-20. PubMed ID: 15596707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.